3,4-methylenedioxyamphetamine has been researched along with MS (Multiple Sclerosis) in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Navidian, A | 1 |
| Rezaee, N | 1 |
| Baniasadi, F | 1 |
| Shakiba, M | 1 |
| Walsh, A | 1 |
| Walsh, PA | 1 |
1 trial available for 3,4-methylenedioxyamphetamine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Effect of a Couples' Relationship Enrichment Program on the Quality of Marital Relationships from the Perspective of Spouses of Patients with Multiple Sclerosis.
Topics: Adult; Family Therapy; Female; Humans; Iran; Love; Male; Marriage; Middle Aged; Multiple Sclerosis; | 2017 |
1 other study available for 3,4-methylenedioxyamphetamine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Love, self-esteem, and multiple sclerosis.
Topics: Activities of Daily Living; Adaptation, Psychological; Attitude to Health; Humans; Love; Middle Aged | 1989 |